Creative Planning Pa Vmed Inc. Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$0.22 - $0.5 $103 - $235	-470 Reduced 3.98%	11,344 $3,000
Q2 2023 Jul 21, 2023	BUY	$0.35 - $0.56 $426 - $682	1,219 Added 11.51%	11,814 $4,000
Q1 2023 May 15, 2023	SELL	$0.36 - $0.63 $438 - $767	-1,219 Reduced 10.32%	10,595 $3,000
Q3 2022 Nov 03, 2022	BUY	$0.57 - $34.65 $6,733 - $409,355	11,814 New	11,814 $10,000
Q2 2021 Aug 04, 2021	SELL	$3.95 - $6.88 $624,641 - $1.09 Million	-158,137 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.01 - $5.55 $126,959 - $350,560	63,164 Added 66.51%	158,137 $702,000
Q4 2020 Jan 29, 2021	BUY	$1.73 - $2.13 $164,303 - $202,292	94,973 New	94,973 $201,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $58.2M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.